BioSpace News Archive

Mersana Therapeutics, Inc. today announced that members of management will participate in a fireside chat at Guggenheim’s 6th Annual Biotechnology Conference on February 8, 2024 at 11:30 a.m. ET.

Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company) today announced that a poster outlining its pivotal Phase 3 STRIVE-ON safety trial (the STRIVE-ON trial–NCT05995405) has been accepted for presentation at the 2024 International Stroke Conference, to be held February 7-9, 2024 in Phoenix, AZ.

Sensus Healthcare, Inc. announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders.

Soleno Therapeutics, Inc. today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the following upcoming investor conferences.

Prime Medicine, Inc. (Nasdaq: PRME) today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 2:00 p.m. ET in New York, NY.

The NICA Accreditation Program and the National Infusion Center Association are proud to announce that DENT Neurologic Institute has earned the National Infusion Center Association Accreditation of Excellence for Ambulatory Infusion Centers.

BrainCheck, Inc. will showcase the latest version of its comprehensive cognitive assessment platform and 3-minute screening tool, BrainCheck Screen™, in booth #32 at the NeuroNet Summit 2024 from February 1-3 in Las Colinas, TX.

The Board of Acarix AB (publ) announces the immediate appointment of Aamir Mahmood as its new CEO, effective February 1.

FORE Biotherapeutics today announced that the Company, will participate at the following investor conferences.

Surmodics, Inc. today reported financial results for its first quarter ended December 31, 2023, and updated its financial guidance for fiscal year ending September 30, 2024.